The Diagnostic Potential of Gut Microbiota-Derived Short-Chain Fatty Acids in Preeclampsia
Open Access
- 3 June 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 10, 878924
Abstract
Preeclampsia (PE) is a complex pregnancy-related hypertensive disorder leading to multiorgan dysfunction. It has high maternal, fetal, and neonatal morbidity and mortality rates. The study of gut microbiota and its metabolites in PE deserves further exploration. Thirty-eight pregnant women with PE and 29 healthy pregnant women in the third trimester of their pregnancy were recruited in this study. We used a targeted metabolomics approach to evaluate the short-chain fatty acids (SCFAs) in serum samples. The correlation between SCFAs and clinical characteristics was also explored. The results of mass spectrometry (MS) showed significant differences at the metabolomics level of SCFAs between the PE and healthy control. The metabolic levels of acetate, propionate, isobutyrate, and valerate were significantly increased in the PE group than in the healthy control group. In contrast, caproic acid and butyrate levels were significantly reduced. The correlation analysis showed that urea, systolic, and diastolic blood pressure levels were positively correlated with four types of SCFAs (acetic acid, propionic acid, isobutyric acid, and valeric acid) which increased in the PE group. Furthermore, the neutrophil percentage and the fetal birth weight were negatively correlated with isobutyric acid and valeric acid. In addition, the receiver operating characteristic (ROC) analysis using a generalized linear model showed that multiple SCFAs would be potential diagnostic markers for PE, with high specificity, sensitivity, and area under the curve (AUC). Among them, isobutyric acid (sensitivity: 97.4%, specificity: 100%, AUC = 1.00), propionic acid (sensitivity: 86.8%, specificity: 93.3%, AUC = 0.954) and acetic acid (sensitivity: 86.8%, specificity: 83.3%, AUC = 0.891) depicted significantly higher diagnostic value and potential clinical applications. In summary, the results of this study indicate that SCFAs have the potential to become effective biomarkers for early screening of PE.Keywords
This publication has 27 references indexed in Scilit:
- Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With PreeclampsiaFrontiers in Cellular and Infection Microbiology, 2019
- Diet-Gut Microbiota Interactions and Gestational Diabetes Mellitus (GDM)Nutrients, 2019
- A High Salt Diet Modulates the Gut Microbiota and Short Chain Fatty Acids Production in a Salt-Sensitive Hypertension Rat ModelNutrients, 2018
- The effects of gut microbiota on metabolic outcomes in pregnant women and their offspringFood & Function, 2018
- The Impact of Dietary Fiber on Gut Microbiota in Host Health and DiseaseCell Host & Microbe, 2018
- Gut microbiome, metabolome, and allergic diseasesAllergology International, 2017
- Role of short-chain fatty acids in disease treatmentWorld Chinese Journal of Digestology, 2017
- Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty AcidsPLOS ONE, 2016
- Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early PregnancyHypertension, 2016
- Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulationProceedings of the National Academy of Sciences, 2013